p53 protein expression in benign and malignant breast lesions. 1998

A Ioakim-Liossi, and C Markopoulos, and P Karakitsos, and M Safioleas, and J Gogas, and G Vaiopoulos
Department of Pathology, Medical School, University of Athens, Greece.

OBJECTIVE To investigate p53 protein expression in imprints from benign and ductal breast carcinoma cases in relation to the histologic grade of malignancy and clinical stage. METHODS The study group consisted of 60 cases of primary ductal breast carcinomas and 20 benign lesions. For the demonstration of p53 protein expression, an immunocytochemical avidin-extravidin complex technique was applied. Monoclonal antibody p53 was used as the primary antibody, diaminobenzidine as the chromogen and hematoxylin as the counterstain. RESULTS Forty-five percent of breast cancer cases showed positive expression of p53. A statistically significant difference in p53 protein expression was observed between grade 1, 2 and 3 carcinomas and stage I, II and III cases. All benign lesions were negative for p53 protein expression. CONCLUSIONS Immunocytochemical p53 protein expression in cytologic material is a simple method that can be applied in routine cytologic laboratories for the identification of genetic alterations in primary ductal breast cancer.

UI MeSH Term Description Entries
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D005260 Female Females
D005348 Fibrocystic Breast Disease A common and benign breast disease characterized by varying degree of fibrocystic changes in the breast tissue. There are three major patterns of morphological changes, including FIBROSIS, formation of CYSTS, and proliferation of glandular tissue (adenosis). The fibrocystic breast has a dense irregular, lumpy, bumpy consistency. Breast Dysplasia,Fibrocystic Mastopathy,Mammary Dysplasia,Adenosis of Breast,Chronic Cystic Mastitis,Cystic Breast Disease,Cystic Disease of Breast,Fibrocystic Changes of Breast,Fibrocystic Disease of Breast,Microglandular Adenosis,Adenoses, Microglandular,Adenosis, Microglandular,Breast Adenosis,Breast Cystic Disease,Breast Cystic Diseases,Breast Disease, Cystic,Breast Disease, Fibrocystic,Breast Fibrocystic Change,Breast Fibrocystic Changes,Breast Fibrocystic Disease,Cystic Mastitis, Chronic,Disease, Cystic Breast,Disease, Fibrocystic Breast,Dysplasia, Breast,Dysplasia, Mammary,Mastopathy, Fibrocystic,Microglandular Adenoses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016159 Tumor Suppressor Protein p53 Nuclear phosphoprotein encoded by the p53 gene (GENES, P53) whose normal function is to control CELL PROLIFERATION and APOPTOSIS. A mutant or absent p53 protein has been found in LEUKEMIA; OSTEOSARCOMA; LUNG CANCER; and COLORECTAL CANCER. p53 Tumor Suppressor Protein,Cellular Tumor Antigen p53,Oncoprotein p53,TP53 Protein,TRP53 Protein,p53 Antigen,pp53 Phosphoprotein,Phosphoprotein, pp53
D018226 Fibroadenoma An adenoma containing fibrous tissue. It should be differentiated from ADENOFIBROMA which is a tumor composed of connective tissue (fibroma) containing glandular (adeno-) structures. (From Dorland, 27th ed) Fibroadenomas
D018270 Carcinoma, Ductal, Breast An invasive (infiltrating) CARCINOMA of the mammary ductal system (MAMMARY GLANDS) in the human BREAST. Carcinoma, Infiltrating Duct,Carcinoma, Invasive Ductal, Breast,Carcinoma, Mammary Ductal,Invasive Ductal Carcinoma, Breast,Mammary Ductal Carcinoma,Carcinomas, Infiltrating Duct,Carcinomas, Mammary Ductal,Mammary Ductal Carcinomas

Related Publications

A Ioakim-Liossi, and C Markopoulos, and P Karakitsos, and M Safioleas, and J Gogas, and G Vaiopoulos
January 1991, Anticancer research,
A Ioakim-Liossi, and C Markopoulos, and P Karakitsos, and M Safioleas, and J Gogas, and G Vaiopoulos
December 2016, Investigacion clinica,
A Ioakim-Liossi, and C Markopoulos, and P Karakitsos, and M Safioleas, and J Gogas, and G Vaiopoulos
April 2004, Histology and histopathology,
A Ioakim-Liossi, and C Markopoulos, and P Karakitsos, and M Safioleas, and J Gogas, and G Vaiopoulos
March 1993, The British journal of dermatology,
A Ioakim-Liossi, and C Markopoulos, and P Karakitsos, and M Safioleas, and J Gogas, and G Vaiopoulos
January 2001, The Histochemical journal,
A Ioakim-Liossi, and C Markopoulos, and P Karakitsos, and M Safioleas, and J Gogas, and G Vaiopoulos
January 1993, Histopathology,
A Ioakim-Liossi, and C Markopoulos, and P Karakitsos, and M Safioleas, and J Gogas, and G Vaiopoulos
January 2000, Anticancer research,
A Ioakim-Liossi, and C Markopoulos, and P Karakitsos, and M Safioleas, and J Gogas, and G Vaiopoulos
October 1995, European journal of cancer (Oxford, England : 1990),
A Ioakim-Liossi, and C Markopoulos, and P Karakitsos, and M Safioleas, and J Gogas, and G Vaiopoulos
October 1997, International journal of cancer,
A Ioakim-Liossi, and C Markopoulos, and P Karakitsos, and M Safioleas, and J Gogas, and G Vaiopoulos
January 1996, Anticancer research,
Copied contents to your clipboard!